1561 – 1570 of 2187
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Inhibitor development.
(
- Contribution to journal › Article
-
Mark
N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
(
- Contribution to journal › Article
-
Mark
Advances in understanding pathogenic mechanisms of thrombophilic disorders.
(
- Contribution to journal › Article
-
Mark
Haemophilia in the first years of life.
(
- Contribution to journal › Article
-
Mark
The tetraspanin CD63 is involved in granule targeting of neutrophil elastase.
(
- Contribution to journal › Article
-
Mark
Protecting the joints of mice and men.
(
- Contribution to journal › Article
-
Mark
FLT3 ligand and not TSLP is the key regulator of IL-7-independent B-1 and B-2 B Lymphopoiesis.
(
- Contribution to journal › Article
-
Mark
The EUROclass trial: defining subgroups in common variable immunodeficiency.
(
- Contribution to journal › Article
-
Mark
Gene therapy of Diamond Blackfan anemia CD34(+) cells leads to improved erythroid development and engraftment following transplantation.
(
- Contribution to journal › Article
-
Mark
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.
(
- Contribution to journal › Article